"Dyadic International (NASDAQ: DYAI) Revolutionizing Pharma with Innovative C1 Technology for Global Protein Development" -January 03, 2024 at 04:38 am EST

Card image cap

The biotechnology firm, specializing in the creation of microbial and fungal-based gene expression technology platforms, appears poised to potentially transform the pharmaceutical sector with its...

Related Keywords

Florida , United States , Netherlands , , Dyadic International , Nasdaq , Dupont , Dyadic International Inc , Private Securities Litigation Reform Act , Markets ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.